Delivery Order SPE2DB20D9332-SPE2DB25FV3B5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for BOTOX 100 unit vials on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee based on its established...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $46,148.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of the drug Botox, with a completion date of July 12, 2024. This order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $48,569.85 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with an ultimate completion date of September 2, 2025. The contract carries no set-aside designation, and the awardee will supply the pharmaceutical product to support federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,234.25 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery to Park Ridge with an ultimate completion date of August 26, 2025. This contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal marketplace...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Botox 200 unit vials. The contract, valued at $5,508.60, has an ultimate completion date of April 10, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a comprehensive range of pharmaceutical products and medical supplies to federal government...
- The Defense Logistics Agency awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract with an ultimate completion date of September 4, 2025. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive positioning in federal...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of BOTOX with a potential value of $5,537.76 and a completion date of February 29, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,762.20 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 Unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will deliver the product to Park Ridge, IL with a completion deadline of September 3, 2025. This delivery order was issued without set-aside designation and was awarded on August 12, 2025. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
- SPE2DB20D9332Indefinite Delivery Contract
- SPE2DB20D9332-SPE2DB25FV3B5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will supply this specialty pharmaceutical product to support Defense Department healthcare requirements. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC, awarded under the SPE2DB program, authorizes the agency to procure a comprehensive range of pharmaceutical products including prescription medications, biologics, and medical consumables to support military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain since its registration in 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized medical products, including oncology treatments and injectable therapeutics, directly to Department of Defense healthcare sites globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 8/13/25 |